VNI Virginia Neurological Institute

The Virginia Neurological Institute (VNI) is a pioneering effort, spearheaded by the neurosurgery department, to create an international center of excellence that will overcome current hindrances in the advancement of the neurosciences and seize unparalleled opportunities they hold for the 21st century. The mission of the VNI is to provide the highest quality care at the lowest cost to the largest number of patients; to discover and develop new cost-effective approaches for preventing, diagnosing, and treating neurologic diseases; and to train future leaders in neurology, neurosurgery, neuroscience nursing, and related disciplines.

The VNI promotes and coordinates patient care, research, and teaching activities of the University of Virginia neuroscience community through 14 clinical interdisciplinary centers where care and research are tailored to the specific nature of each disorder: general neurology, general neurosurgery, epilepsy, neuroendocrine, neuro-oncology, neurorehabilitation, neurotrauma, Parkinson's and Alzheimer's diseases, pediatric neurology, pediatric neurosurgery, peripheral nerve and neuromuscular disorders, radiosurgery, spine, and stroke. Its core support services offer a supplementary mechanism for obtaining funding, recruiting personnel, purchasing goods and services, administering research programs, and acquiring space in a timely, flexible manner.

The Institute's unique environment, created by its interdisciplinary approach, novel organizational structure, contemporary facilities, and state-of-the-art equipment has attracted current and future leaders of the clinical and basic neurosciences; the chairs of the neurology and neurosurgery departments and other faculty members were recently named among "the best doctors" in national surveys. In addition to the 14 centers and support services, the VNI operates the Advanced Technology Research Center (which includes informatics projects, the Neurovisualization Laboratory, and the Telemedicine Laboratory), and the Neuroclinical Trials Center.